Sixteen law firms and accounting firms have thrown their hat in the ring to administer a $300 million settlement in two class actions against Johnson & Johnson over pelvic mesh devices that injured thousands of women.
A contradictor appointed in two pelvic mesh class actions against Johnson & Johnson has blasted a $300 million settlement, calling it “massively” short of what is owed to group members, after a judge preliminarily found the sum was not fair and reasonable.
Australia’s largest private health insurer Medibank has flagged an application to stay a landmark data breach class action filed in the Federal Court, as another law firm mulls a class action over the massive breach.
A landmark Federal Court class action against private health insurer Medibank will be a test case for when privacy claims can sidestep the regulatory path, and whether group members can prove they suffered loss from exposure of their data.
Australia’s largest private health insurer Medibank is facing a class action over a data breach that affected close to 10 million customers.
The applicant in a Shine Lawyers-run class action against Boston Scientific over alleged defective pelvic mesh wants to switch legal representation, taking her business to Shine’s former class actions head, who recently parted ways with the firm to launch her own boutique.
Regenerative medicine company Mesoblast has hit back at a shareholder class action over its Remestemcel-L treatment for COVID-19, saying that some group members are barred from bringing claims because of a settlement reached in a US class action.
Monash IVF has hit back at a class action brought on behalf of hundreds of men and women demanding damages for the alleged destruction of potentially viable embryos, saying patients “were made aware of the risks” of a novel testing technique.
Three class action law firms have joined forces to run a landmark data breach complaint against Medibank, seeking compensation for up to 9.7 million affected customers.
An Adelaide digital printing firm has brought a case against two healthcare companies in the United States, challenging a patent for producing 3D printed, artificial cadavers used in medical training and research.